Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-12

Clinical Trial Update: 5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing 5-fluorouracil with and without a viscoelastic formulation to prevent scarring after trabeculectomy in glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Glaucoma, Trabeculectomy | Phase 4 | Status: COMPLETED